Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00342693 · ClinicalTrials.gov registry record
Thyroid Abnormalities Associated With Exposure to Atmospheric Emissions of Radioactive Iodine
A clinical trial, sponsored by National Cancer Institute (NCI).
- Terminated
- Registry status
- 360
- Enrollment target
NCT00342693: Clinical Trial study, sponsored by National Cancer Institute (NCI).
NCT00342693 is a clinical trial that was terminated before completion, run by National Cancer Institute (NCI). The registered enrollment target is 360 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00342693 was terminated before completion, sponsored by National Cancer Institute (NCI).
- TERMINATED
- Registry status
- 360 participants
- Enrollment target
Study Summary
Background: * An inadequate filtering system at the Mayak nuclear weapons production facility in Ozyorsk, Russia, allowed the release of various radioactive materials, particularly I-131 (radioactive iodine) into the city's atmosphere during the 1950s. * A recent pilot study found a higher prevalence of thyroid nodules in Ozyorsk residents who were exposed to the radiation in childhood during years of heavy atmospheric emissions (1952-1953) than in children exposed in later years (between 1967 and 1991) when there were almost no radioactive releases. * Understanding the role of I-131 in the development of thyroid disease is important because I-131 is commonly used in medicine (e.g., to treat hyperthyroidism and thyroid cancer and to diagnose thyroid disease), and it is the major source of thyroid gland exposure in fallout from atomic bomb explosions, nuclear power plant accidents, and atmospheric venting from plutonium manufacturing facilities. Objectives: -To expand the pilot study to include 350 Ozyorsk residents who were exposed in childhood to moderate levels of radiation in order to evaluate thyroid disease in relation to the dose of I-131 exposure. Eligibility: -People who were born and living in Ozyorsk, Russia between 1954 and 1955, the period of mild radioactive releases from the Mayak nuclear weapons plant. Design: * Participants' thyroid gland and structure are examined with an ultrasound examination and blood tests. * Participants with a possible thyroid gland disorder are referred to specialists for additional diagnostic procedures.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2006-02-21 |
| Est. Completion | 2013-09-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00342693
The ClinicalTrials.gov registry entry for NCT00342693 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00342693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00342693 about?
NCT00342693 is a clinical study titled "Thyroid Abnormalities Associated With Exposure to Atmospheric Emissions of Radioactive Iodine". Background: * An inadequate filtering system at the Mayak nuclear weapons production facility in Ozyorsk, Russia, allowed the release of various radioactive materials, particularly I-131 (radioactive iodine) into the city's atmosphere during the 1950s. * A recent pilot study found a higher prevalen...
What is the current status of trial NCT00342693?
This trial is currently terminated. The enrollment target is 360 participants. The study started on 2006-02-21. Estimated completion is 2013-09-03.
Who is sponsoring clinical trial NCT00342693?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.